Opening OBESITY AND IT'S MANAGEMENT PART - DR . NITIN KAPOOR
OBESITY AND IT'S MANAGEMENT PART - DR . NITIN KAPOOR
- Length
- 41 min
- Level
- Undergraduate
- Recorded
- Christian Medical College Vellore2024
Chapter 1 of 5: Before the lecture
Obesity management requires an updated approach focused on modern pharmacotherapy and patient-centered health outcomes rather than simple calorie counting. The presentation details the epidemiological shift of obesity in India, the physiological mechanisms of novel anti-obesity medications, and the role of combination therapies. It examines specific drug classes, including GLP-1 receptor agonists, dual agonists like tirzepatide, and triple receptor agonists. Finally, it outlines the Edmonton Obesity Staging System for clinical evaluation and discusses the emerging role of genetic testing in early-onset cases.

Your comment is kept while you sign up.Sign in
Surveys the pharmacology of novel anti-obesity medications and their clinical indications.
Obesity management requires an updated approach focused on modern pharmacotherapy and patient-centered health outcomes rather than simple calorie counting. The presentation details the epidemiological shift of obesity in India, the physiological mechanisms of novel anti-obesity medications, and the role of combination therapies. It examines specific drug classes, including GLP-1 receptor agonists, dual agonists like tirzepatide, and triple receptor agonists. Finally, it outlines the Edmonton Obesity Staging System for clinical evaluation and discusses the emerging role of genetic testing in early-onset cases.
Epidemiology of overweight and obesity in Indian adults - A secondary data analysis of the National Family Health Surveys
Factors Contributing to the Change in Overweight/Obesity Prevalence Among Indian Adults: A multivariate decomposition analysis of data from the National Family Health Surveys
The BMI-adiposity conundrum in South Asian populations: need for further research
Prevalence of normal weight obesity and its associated cardio-metabolic risk factors - Results from the baseline data of the Kerala Diabetes Prevention Program (KDPP)
ESI Clinical Practice Guidelines for the Evaluation and Management of Obesity in India
RSSDI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2022
Obesity Indicators and Health-related Quality of Life - Insights from a Cohort of Morbidly Obese, Middle-aged South Indian Women
The SECURE model: A comprehensive approach for metabolic obesity. Management
Nat Rev Drug Discov
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Tirzepatide Once Weekly for the Treatment of Obesity
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2)
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
This lecture
Lecture 14 of 39 of PG LECTURES.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.
Redefining Obesity: Beyond the Numbers
Consensus on Current Landscape and Treatment Trends of Obesity in India for Primary Care Physicians
A proposed clinical staging system for obesity
Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity
Visceral Medicine data on weight maintenance
Genetics of obesity in consanguineous populations - A road map to provide novel insights in the molecular basis and management of obesity
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency